Atlas Trials

Real-world Study on the Efficacy, Safety, and Prognostic Factors of Immune Checkpoint Inhibitors Combined With Radiotherapy in Patients With Malignant Tumors: A Prospective Non-interventional Clinical Study

Clinical trial NCT07665736 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07665736
Sponsor
Sichuan University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
RadiotherapyImmune Checkpoint Inhibitors (ICIs)
Start date
2026-06-30
Primary completion
2029-06-15
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.